NCT00958789

Brief Summary

This study will be a prospective, non-randomized evaluation of the change between preoperative and postoperative outcomes for those receiving the Triathlon® TS Total Knee System for a revision knee operation. The mean total Knee Society Score (for pain, motion and function) change is not 10% worse than, or is superior to, the expected change according to published revision total knee replacement data, for cases implanted with the Triathlon® TS Total Knee System as compared from preoperative to 2 years postoperative.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2009

Longer than P75 for not_applicable

Geographic Reach
1 country

12 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2009

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

August 11, 2009

Completed
2 days until next milestone

First Posted

Study publicly available on registry

August 13, 2009

Completed
6.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 25, 2016

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

May 19, 2017

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 28, 2019

Completed
Last Updated

October 22, 2021

Status Verified

October 1, 2021

Enrollment Period

6.8 years

First QC Date

August 11, 2009

Results QC Date

April 11, 2017

Last Update Submit

October 21, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Knee Society Score (KSS) Change From Preoperative Time Point to 2 Years

    KSS Pain score, KSS Function score, Total Combined KSS The Knee Society Clinical Rating System is comprised of two distinct sub-scores: one for pain, range of motion (ROM) and joint stability, and one for functional parameters. Sub-scores range from a potential minimum score of 0 to a maximum score of 100 points. Although the specific scores are not distinguished as "excellent," "good," "fair," or "poor," a higher value represents a better outcome. Additionally, the KSS Pain subscore and KSS Function subscore are added together to obtain a total combined score (minimum score 0, maximum score 200).

    pre-op, 2 years

Secondary Outcomes (10)

  • Knee Society Score (KSS) Functional Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative

    2 years, 5 years

  • Knee Stability Results Stratified by Joint Line Restoration Groups at 2 and 5 Year Postoperative

    2 year and 5 year postoperative

  • Anterior Knee Pain Results Stratified by Joint Line Restoration Groups at 2 and 5 Years Postoperative

    2 year and 5 year postoperative

  • Short Form Health Survey (SF-36) Health Survey Change From Pre-op to Post-op Visits

    pre-op, 1, 2, 5 years

  • Number of Knees With Radiographic Stability at 1, 2 and 5 Years Postoperative

    1, 2, 5 years

  • +5 more secondary outcomes

Study Arms (1)

Triathlon TS Knee

OTHER

Triathlon TS Knee System

Device: Triathlon TS Knee System

Interventions

Total knee replacement for revision cases

Triathlon TS Knee

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patient has signed an Institutional Review Board (IRB) approved, study specific Informed Patient Consent Form.
  • Patient is a male or non-pregnant female age 18 years or older at time of study device implantation.
  • Patient is a candidate for revision of all femoral and tibial components of a total knee replacement.
  • Patient is willing and able to comply with postoperative scheduled clinical and radiographic evaluations and rehabilitation.

You may not qualify if:

  • Patient has a Body Mass Index (BMI) \> 40.
  • Patient has an active or suspected latent infection in or about the affected knee joint at time of study device implantation.
  • Patient has a neuromuscular or neurosensory deficiency, which limits the ability to evaluate the safety and efficacy of the device.
  • Patient is diagnosed with a systemic disease (e.g. Lupus Erythematosus) or a metabolic disorder (e.g. Paget's Disease) leading to progressive bone deterioration.
  • Patient is immunologically suppressed or receiving steroids in excess of normal physiological requirements (e.g. \> 30 days).
  • Patient has a failed unicondylar knee prosthesis.
  • Patient has a known sensitivity to device materials.
  • Patient is a prisoner.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

The CORE Institute

Phoenix, Arizona, 85023, United States

Location

Heekin Institute for Orthopedic Research

Jacksonville, Florida, 32204, United States

Location

Midwest Orthopaedics at Rush

Chicago, Illinois, 60612, United States

Location

Tufts Medical Center

Boston, Massachusetts, 02111, United States

Location

Rothman Institute

Egg Harbor, New Jersey, 08234, United States

Location

Ridgewood Orthopedics

Ridgewood, New Jersey, 07450, United States

Location

Upstate Bone and Joint Center

East Syracuse, New York, 13057, United States

Location

University of North Carolina Orthopedics

Chapel Hill, North Carolina, 27599, United States

Location

Duke University Medical Center

Durham, North Carolina, 27703, United States

Location

Wellington Orthopaedic & Sports Medicine

Cincinnati, Ohio, 45255, United States

Location

The Orthopaedic Center

Tulsa, Oklahoma, 74120, United States

Location

Scott & White Clinic

Temple, Texas, 76508, United States

Location

Results Point of Contact

Title
Ellen Axelson, Director, Clinical Operations
Organization
Stryker Orthopaedics

Study Officials

  • Kirby D Hitt, M.D.

    Scott & White Hospital

    STUDY CHAIR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 11, 2009

First Posted

August 13, 2009

Study Start

July 1, 2009

Primary Completion

April 25, 2016

Study Completion

March 28, 2019

Last Updated

October 22, 2021

Results First Posted

May 19, 2017

Record last verified: 2021-10

Locations